| 摘要 |
<p>Disclosed herein are methods and compositions useful for the diagnosis and treatment of angiogenic disorders, including, e.g., cancer. In particular, marker genes suitable for predicting whether or not a patient will respond to anti-NRP1, anti -VEGFC and anti-EGFL7 treatment are diclosed.</p> |
